Circulating biochemical markers of bone remodeling in uremic patients.
about
Regulation of bone remodeling: impact of novel therapies.Calpain 1 inhibitor BDA-410 ameliorates α-klotho-deficiency phenotypes resembling human aging-related syndromes.Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.Discriminants of prevalent fractures in chronic kidney diseaseBone metabolism and mineral density following renal transplantationThe five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patientsSuppressed bone remodeling in black bears conserves energy and bone mass during hibernation.Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patientsThe Association between Elevated Levels of Peripheral Serotonin and Its Metabolite - 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney DiseaseRisk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism.Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortalityDiagnosis of renal osteodystrophy.Circulating multimarker profile of patients with symptomatic heart failure supports enhanced fibrotic degradation and decreased angiogenesis.Biomarker candidates for cardiovascular disease and bone metabolism disorders in chronic kidney disease: a systems biology perspectiveOxidative Stress as Estimated by Gamma-Glutamyl Transferase Levels Amplifies the Alkaline Phosphatase-Dependent Risk for Mortality in ESKD Patients on Dialysis.Mammalian hibernation as a model of disuse osteoporosis: the effects of physical inactivity on bone metabolism, structure, and strength.(18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease.The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients.The effect of nephrectomy on Klotho, FGF-23 and bone metabolism.Parathyroid enlargement at dialysis initiation in patients with chronic kidney diseases.The role of cardiac biochemical markers in aortic stenosis.Biomarkers Predicting Bone Turnover in the Setting of CKD.Acute calcium kinetics in haemodialysis patients.Bone-specific alkaline phosphatase and bone turnover in African American hemodialysis patients.Carboxylated and intact osteocalcin predict adiponectin concentration in hemodialyzed patients.Adynamic bone disease-bone and beyond.Noninvasive assessment of bone health in Indian patients with chronic kidney disease.Serum osteocalcin levels are useful as a predictor of cardiovascular events in maintenance hemodialysis patients.Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.The evaluation of renal osteodystrophy with cortical quantitative ultrasound at various bone sites.Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism.The role of prolidase activity in the diagnosis of uremic bone disease.The use of bone turnover markers in chronic kidney disease-mineral and bone disorders.New Biochemical Serum Markers of Boneturnover in Renal Osteodystrophy.Fragility Fractures in Chronic Kidney Disease: Assessment and Pharmacologic Management
P2860
Q32029051-2309F64A-926F-4789-8452-8F0A1BA12E63Q33986838-FB0A0769-70F4-4CD0-9B02-A69B6830F86DQ35058295-DFD52F17-A9B0-4088-A6E2-8E9BC5653E4AQ35142758-0956BB69-17E0-4FB2-840A-FC3D4DC8918BQ35267104-CFA3CE6A-42F3-450B-A756-E9F29A6075DAQ35848015-CB00C4AB-1BCB-495A-AB49-6DFEB5AAACD8Q35878081-2065C6F9-2820-48E4-980B-0EED92BA0F1FQ36035872-FF9BEEDD-B424-402C-B1C7-230F77291EC9Q36155291-0DEF3B10-5690-4F21-862E-1C430ED7D9BAQ36245734-E42E3CCA-A505-422B-BAFC-A3EA9E2A84A4Q36492567-D260EADD-CC45-488E-9C44-9C8C4782BEA9Q36554773-3913174B-A289-44EE-8B88-57DE47B034ABQ36753619-61B1930F-2085-40C9-9339-F46FF77CC46AQ37081787-92C25F7A-7432-4BE9-9C37-A36929DECAA9Q37156964-ABBA6597-B67B-4F57-8C1D-20B9B23481BBQ37200108-DC03AACA-D066-476A-8380-42BF53B57E29Q37298652-CE0EF014-7633-4F66-BF16-FF238969B68BQ37670856-342DCA7B-75DA-4727-A2AA-D4E24E505959Q37710161-32EB8275-0370-4756-96B3-E5463F5B1B24Q38078963-5A027980-4074-4CDF-B62C-17EC3C5DEB2AQ38743657-74EBBB84-2D65-44C9-9C82-79CC1381DDF3Q39254025-ED59B872-989C-46FB-9AA0-827AAED592AEQ39334809-CF6B0C02-F2D6-43CB-816A-E3669238A062Q39650613-71D40B78-5828-4BE5-BED2-D0A2897F69B2Q40046970-2D6613EF-CB02-4E96-96F1-5C6826368C0EQ40319624-82B2F35A-CE54-4272-82AB-ACA8BB4D2515Q42092498-0E6A06E0-786B-482D-A982-DA183673CE2EQ44170370-DB279C52-5666-4B5C-BECA-48D52D46C3CAQ44552901-7EB99046-78DF-4D5F-BFBC-3CCED2133EB1Q45049662-DEB531E6-A561-4D8A-8101-86C978A7D80AQ51400520-9DE9D336-E052-4F20-80AD-228199D71CCFQ51939952-FE299644-56E6-4687-86DD-C10A8E5709CFQ53743050-88270672-00E1-4F7E-BCE4-90CB13B3F4E7Q55533717-E0C21CA2-3F31-4581-B754-BD666115EF95Q59051207-7F9F005D-AA75-43AF-860A-7C71ADF793CA
P2860
Circulating biochemical markers of bone remodeling in uremic patients.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Circulating biochemical markers of bone remodeling in uremic patients.
@ast
Circulating biochemical markers of bone remodeling in uremic patients.
@en
type
label
Circulating biochemical markers of bone remodeling in uremic patients.
@ast
Circulating biochemical markers of bone remodeling in uremic patients.
@en
prefLabel
Circulating biochemical markers of bone remodeling in uremic patients.
@ast
Circulating biochemical markers of bone remodeling in uremic patients.
@en
P1433
P1476
Circulating biochemical markers of bone remodeling in uremic patients.
@en
P2093
M C De Vernejoul
P304
P356
10.1046/J.1523-1755.1999.00461.X
P407
P577
1999-06-01T00:00:00Z
P5875
P6179
1035921560